EXPRESSION OF A CONSTITUTIVE NF-KAPPA-B-LIKE ACTIVITY IS ESSENTIAL FOR PROLIFERATION OF CULTURED BOVINE VASCULAR SMOOTH-MUSCLE CELLS

EXPRESSION OF A CONSTITUTIVE NF-KAPPA-B-LIKE ACTIVITY IS ESSENTIAL FOR PROLIFERATION OF CULTURED BOVINE VASCULAR SMOOTH-MUSCLE CELLS
复制标题

DOI:
10.1172/jci118313
复制
发表时间:
1995-11-01
影响因子:
15.9
通讯作者:
SONENSHEIN, GE
SONENSHEIN, GE
中科院分区:
医学1区
文献类型:
--
作者:
BELLAS, RE;LEE, JS;SONENSHEIN, GE

文献摘要

被引文献

相似文献

我们最近发现牛和人血管平滑肌细胞(SMC)表达新的组成型核因子-κ B(NF-κ B)/Rel样活性(Lawrence,R.,L- J. Chang,U. Siebenlist,P. Bressler,and G. E.索南辛1994. 269:28913-28918),在此称为SMC-Rel.由于人血管平滑肌细胞的巨细胞病毒(CMV)感染与血管成形术后再狭窄过程中平滑肌细胞的异常增殖有关,我们检测了NF-κ B/Rel活性在CMV立即早期(即)启动子反式激活中的作用。基础CMV ie启动子与其NF-κ B元件的三个野生型拷贝相连,但不是突变型拷贝,在牛主动脉SMC中具有活性。临床上用于降低NF-κ B/Rel活性的抗氧化剂N-乙酰半胱氨酸(NAC)或戊乙茶碱(PTX)抑制NF-κ B驱动的启动子反式激活和SMC-Rel结合活性。观察到用NAC或PTX处理以剂量依赖性方式减缓SMC的生长。显微注射纯化的I κ B-α(一种天然存在的NF-κ B/Rel活性特异性抑制剂)或携带野生型但非NF-κ B元件非结合突变体的双链寡核苷酸选择性抑制SMC增殖。因此,组成性NF-κ B/Rel活性似乎是血管平滑肌细胞增殖所必需的,并可能成为再狭窄治疗干预的新靶点。
We have recently discovered bovine and human vascular smooth muscle cells (SMCs) express a novel constitutive Nuclear Factor-kappa B (NF-kappa B)/Rel-like activity (Lawrence, R., L.-J. Chang, U. Siebenlist, P. Bressler, and G. E. Sonenshein. 1994. J. Biol. Chem. 269:28913-28918), here termed SMC-Rel. Since cytomegalovirus (CMV) infection of human vascular SMCs has been implicated in aberrant SMC proliferation during post-angioplasty restenosis, we tested the role of NF-kappa B/Rel activity in transactivation of the CMV immediate early (ie) promoter. The basal CMV ie promoter linked to three wild-type, but not mutant, copies of its NF-kappa B element was active in bovine aortic SMCs. The anti-oxidants N-acetyl cysteine (NAC) or pentoxifylline (PTX), which are used clinically to reduce NF-kappa B/Rel activity, inhibited NF-kappa B driven promoter transactivation, and SMC-Rel binding activity. Treatment with either NAC or PTX was observed to slow the growth of the SMCs in a dose dependent fashion. Microinjection of either purified I kappa B-alpha, a naturally occurring specific inhibitor of NF-kappa B/Rel activity, or double-stranded oligonucleotides harboring wild type, but not non-binding mutants of NF-kappa B elements selectively inhibited SMC proliferation. Thus constitutive NF-kappa B/Rel activity appears essential for proliferation of vascular SMCs and might be a novel target for therapeutic intervention for restenosis.